Paradoxical Behavior of Oncogenes Undermines the Somatic Mutation Theory

Biomolecules. 2022 Apr 30;12(5):662. doi: 10.3390/biom12050662.

Abstract

The currently accepted theory on the influence of DNA mutations on carcinogenesis (the Somatic Mutation Theory, SMT) is facing an increasing number of controversial results that undermine the explanatory power of mutated genes considered as "causative" factors. Intriguing results have demonstrated that several critical genes may act differently, as oncogenes or tumor suppressors, while phenotypic reversion of cancerous cells/tissues can be achieved by modifying the microenvironment, the mutations they are carrying notwithstanding. Furthermore, a high burden of mutations has been identified in many non-cancerous tissues without any apparent pathological consequence. All things considered, a relevant body of unexplained inconsistencies calls for an in depth rewiring of our theoretical models. Ignoring these paradoxes is no longer sustainable. By avoiding these conundrums, the scientific community will deprive itself of the opportunity to achieve real progress in this important biomedical field. To remedy this situation, we need to embrace new theoretical perspectives, taking the cell-microenvironment interplay as the privileged pathogenetic level of observation, and by assuming new explanatory models based on truly different premises. New theoretical frameworks dawned in the last two decades principally focus on the complex interaction between cells and their microenvironment, which is thought to be the critical level from which carcinogenesis arises. Indeed, both molecular and biophysical components of the stroma can dramatically drive cell fate commitment and cell outcome in opposite directions, even in the presence of the same stimulus. Therefore, such a novel approach can help in solving apparently inextricable paradoxes that are increasingly observed in cancer biology.

Keywords: SMT; TOFT; cancer reversion; paradoxes; systems biology; tumor microenvironment.

MeSH terms

  • Carcinogenesis / genetics
  • DNA
  • Humans
  • Mutation
  • Neoplasms* / genetics
  • Neoplasms* / pathology
  • Oncogenes / genetics
  • Tumor Microenvironment / genetics

Substances

  • DNA

Grants and funding

This research received no external funding.